IMC congratulates Ontario government on one-year anniversary of FAST program
Ottawa, October 7, 2026 – Innovative Medicines Canada (IMC) congratulates the Ontario government on the one-year anniversary of its Funding […]
Newsroom
Stay informed on the latest developments in life sciences research, healthcare policy, and innovative medicines.
For media inquiries, please contact us at media@imc-mnc.ca.
PRESS RELEASES
New data confirms innovative pharmaceutical industry is a major economic engine for Canada
Ottawa, September 3, 2026 – Innovative Medicines Canada (IMC) welcomes Deloitte Canada’s report showing the innovative pharmaceutical industry is a strategically important sector for Canada’s economic growth and productivity. According to […]
Federal task force report marks important step for Canada’s life sciences sector
Ottawa, July 24, 2026 – Innovative Medicines Canada (IMC) acknowledges today’s publication of the Pharmaceutical and Life Sciences Sector Task […]
Statements
IMC welcomes provincial and territorial focus on health funding
Ottawa, October 19, 2026 – Innovative Medicines Canada (IMC) welcomes the press release issued by provincial and territorial (PT) health […]
Ontario case highlights structural national access issues
Ottawa, October 6, 2026 – The Ontario government’s response today to an Ontario melanoma patient denied out-of-country public coverage for […]
IMC’s open letter to Quebec party leaders
Dear Quebec party leaders, What if we told you about a sector in Quebec that: You’d probably want to make it a priority. Attract it. Grow […]
IN THE NEWS
How Ontario slashed wait times for cancer treatments
By Dr. Bettina Hamelin One year ago, the Ontario government made a decision: Patients shouldn’t have to wait up to […]
Canada is losing the race for clinical trials – and patients are paying the price
By Dr. Bettina Hamelin Canada has long punched above its weight in clinical trial activity: the rigorous, multi-stage research studies […]
Opinion: It’s faster to fly a human around the moon than to get a new drug to Canadians
By Dr. Bettina Hamelin Article originally published on Healthing.ca, July 21, 2026. This spring, Canada made history when astronaut Jeremy Hansen […]
Patient Stories
Areas of work
Better health outcomes start with better policy. Explore the issues where IMC is pushing for change on behalf of patients, healthcare professionals and Canada’s life sciences sector.
Access to medicine
Timely access to new medicines saves lives, improves health outcomes…
Pharmacare
One size does not fit all 97% of Canadians are already eligible for drug coverage. Moving to a one-size-fits-all system […]
Patented Medicine Prices Review Board (PMPRB)
The Patented Medicine Prices Review Board (PMPRB) is responsible for ensuring that patented medicines sold in Canada are not excessively […]
Drugs for rare diseases (DRD)
One in 12 Canadians, two-thirds of them children, lives with a rare disease. IMC advocates for policies that improve and […]
Private drug coverage
The value of private drug coverage in Canada More than 27 million Canadians – nearly 70% of the population – […]
